Investors - Press Releases
|View printer-friendly version|
VigiLanz® Announces Precision Dosing Powered by Tabula Rasa HealthCare’s DoseMeRx™
“Our partnership with
"This partnership means convenient access for
According to TRHC Executive Vice President for DoseMe/Hospitals Business Unit Charles Cornish, the opportunity to integrate DoseMeRx with the
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
DoseMeRx is a
Founded in 2001,
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
|TRHC Media Contact
T: (856) 912-5714
T: (215) 870-0829
VigiLanz Media Contact
T: (410) 534-1161
Source: Tabula Rasa HealthCare, Inc.